Goldman Sachs Group Inc Imara Inc. Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.99 - $1.87 $863,855 - $1.63 Million	872,581 New	872,581 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$0.99 - $1.87 $38,616 - $72,943	39,007 Added 4.68%	872,581 $1.07 Million
Q1 2022 May 16, 2022	SELL	$1.15 - $2.41 $11,700 - $24,519	-10,174 Reduced 1.21%	833,574 $1.57 Million
Q4 2021 Feb 14, 2022	BUY	$2.25 - $4.05 $1.81 Million - $3.26 Million	805,786 Added 2122.61%	843,748 $1.9 Million
Q3 2021 Nov 10, 2021	BUY	$4.08 - $7.83 $154,884 - $297,242	37,962 New	37,962 $155,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.